Drug application
KETAMINE HYDROCHLORIDE (KETAMINE HYDROCHLORIDE)
Drugs@FDA ANDA 219684 · BAXTER HLTHCARE CORP
Key facts
| Drug name | KETAMINE HYDROCHLORIDE |
|---|---|
| Active ingredients | KETAMINE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 219684 |
| Company | BAXTER HLTHCARE CORP |
| Dosage forms | SOLUTION, INTRAMUSCULAR, INTRAVENOUS |
| Strength | EQ 100MG BASE/10ML (EQ 10MG BASE/ML) |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Sep 17, 2025 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.